CRIS Current Research Information System

NANNINI, MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.277
AS - Asia 9.383
EU - Europa 6.237
AF - Africa 633
SA - Sud America 500
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 3
Totale 27.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.105
VN - Vietnam 2.506
SG - Singapore 2.482
CN - Cina 2.321
IT - Italia 1.583
GB - Regno Unito 1.143
DE - Germania 709
HK - Hong Kong 628
SE - Svezia 607
FR - Francia 406
IN - India 394
BR - Brasile 316
RU - Federazione Russa 315
IE - Irlanda 249
CH - Svizzera 242
KR - Corea 223
BD - Bangladesh 221
NL - Olanda 200
CI - Costa d'Avorio 173
UA - Ucraina 171
FI - Finlandia 169
ZA - Sudafrica 160
JP - Giappone 147
TG - Togo 146
CA - Canada 108
EE - Estonia 96
AT - Austria 71
AR - Argentina 70
PH - Filippine 68
PL - Polonia 65
ID - Indonesia 60
SC - Seychelles 56
JO - Giordania 47
BG - Bulgaria 45
BE - Belgio 44
TH - Thailandia 44
NG - Nigeria 41
TW - Taiwan 39
MX - Messico 32
PK - Pakistan 31
IQ - Iraq 29
TR - Turchia 28
IR - Iran 23
ES - Italia 22
CO - Colombia 21
EC - Ecuador 21
GR - Grecia 21
MY - Malesia 20
CL - Cile 19
AU - Australia 18
PE - Perù 14
VE - Venezuela 13
HR - Croazia 12
PY - Paraguay 11
UY - Uruguay 11
EG - Egitto 10
LT - Lituania 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
LB - Libano 8
TN - Tunisia 8
AO - Angola 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
JM - Giamaica 6
CR - Costa Rica 5
ET - Etiopia 5
IL - Israele 5
MU - Mauritius 5
NI - Nicaragua 5
NO - Norvegia 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
DK - Danimarca 4
GH - Ghana 4
MM - Myanmar 4
NP - Nepal 4
SI - Slovenia 4
KE - Kenya 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MA - Marocco 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BW - Botswana 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 27.019
Salva come PNG Salva come JPEG
Città #
Singapore 1.741
Ashburn 1.219
Southend 996
Fairfield 903
Chandler 740
Ho Chi Minh City 582
Hong Kong 572
San Jose 561
Hanoi 466
Hefei 457
Bologna 451
Woodbridge 441
Wilmington 414
Houston 394
Santa Clara 384
Seattle 373
Cambridge 303
Princeton 287
Beijing 282
Ann Arbor 270
Dublin 249
Boardman 222
Bern 219
Seoul 196
Dong Ket 195
Council Bluffs 174
Abidjan 173
Los Angeles 171
New York 170
Lauterbourg 164
Lomé 146
Redmond 142
Dallas 137
Helsinki 123
Nanjing 115
Westminster 111
Tokyo 110
Milan 97
Berlin 96
Padova 91
Haiphong 89
Jacksonville 83
Da Nang 81
Buffalo 76
Rome 74
São Paulo 74
Frankfurt am Main 71
Redondo Beach 68
Turin 68
Jinan 64
Munich 53
Shenyang 53
San Diego 51
Warsaw 49
Johannesburg 48
Vienna 48
Amman 46
Guangzhou 46
Sofia 45
Saint Petersburg 43
Toronto 43
Bengaluru 42
Brussels 42
Jakarta 42
Shanghai 41
Nanchang 40
Zhengzhou 39
Abeokuta 38
Biên Hòa 36
Changsha 36
Falls Church 36
Florence 35
Tianjin 35
Chicago 34
Hyderabad 34
Hangzhou 33
Montreal 33
Bremen 32
Jiaxing 32
Lappeenranta 32
Phoenix 32
London 31
Hebei 30
Hải Dương 30
Orem 30
Des Moines 29
Can Tho 28
San Francisco 28
Amsterdam 27
Dearborn 26
Medford 25
The Dalles 25
Thái Nguyên 25
Kuban 24
Mülheim 23
Denver 22
Falkenstein 22
Yubileyny 22
Brooklyn 21
Olalla 21
Totale 17.423
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 461
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 336
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 281
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 275
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 263
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 260
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 257
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 247
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 247
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 246
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 238
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 237
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 234
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 233
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 226
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 222
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 221
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 221
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 215
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 214
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 214
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 213
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 213
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 213
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 211
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 211
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 210
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 209
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 209
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 208
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 208
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 207
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 207
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 206
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 205
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 202
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 200
Characterization of malignant gastrointestinal stromal tumors-a single center experience. 199
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 197
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 196
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 195
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 195
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 194
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 194
The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC) 193
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches 193
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 193
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 193
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 192
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 190
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 183
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 183
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 182
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 180
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 176
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 176
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 175
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 175
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 174
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 173
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 173
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 172
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 171
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 171
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 171
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 171
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 170
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study 169
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence A Report From the Italian Sarcoma Group 168
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 168
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 168
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 168
SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation 167
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 167
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 167
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 166
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 166
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 165
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 164
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense? (Review) 163
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 163
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis 163
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). 163
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 162
Primary malignant pericardial tumour in Lynch syndrome 161
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST) 161
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 160
Identification of oncogenic events in gastrointestinal stromal tumors (GISTs) by combined gene expression and copy number analysis. 160
Radiotherapy in the management of gist: state of the art and new potential scenarios 158
Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature 158
Exploring the Role of TERT in Thyroid Cancer: A Systematic Review 157
Thoracic myopericytoma in an older adult, rare but possible: A case report 156
Genetic aberrations and molecular biology of cardiac sarcoma 156
Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients 155
The follow-up issues: from the necessity to the opportunity 154
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy 154
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 154
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST). 154
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). 153
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 151
Totale 19.499
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021452 0 0 0 0 0 0 0 0 0 0 0 452
2021/20222.670 282 101 110 183 233 119 63 231 125 169 592 462
2022/20233.411 365 495 178 400 190 231 98 203 542 109 267 333
2023/20241.140 124 165 57 131 98 183 63 85 35 61 62 76
2024/20253.805 197 487 338 294 552 171 302 173 77 259 213 742
2025/202610.362 1.114 875 744 714 996 543 1.264 309 2.060 855 481 407
Totale 27.587